Wayne Markowitz - 11 Sep 2025 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Reporting relationship: CVP, JAPAC
Issuer ticker: EW
Reported as of: 11 Sep 2025
Net transaction value: -$50,420
SEC form: 4
Accepted by SEC: 15 Sep 2025, 18:42:44 UTC
Prior SEC filing: 09 May 2025
Next SEC filing: 08 Dec 2025
Source filing: View source filing
Reporting owner signature: Linda J. Park, Attorney-in-Fact

Key filing fact

Wayne Markowitz filed Form 4 for Edwards Lifesciences Corp (EW) on 15 Sep 2025.

Key facts

This page summarizes Wayne Markowitz's Form 4 filing for Edwards Lifesciences Corp (EW).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 15 Sep 2025, 18:42.

Change

Previous filing in this sequence was filed on 09 May 2025.
Current net transaction value: -$50,420.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001991414 Primary reporting owner

Markowitz Wayne

Relationship: CVP, JAPAC
Address: ONE EDWARDS WAY, IRVINE
Signature: Linda J. Park, Attorney-in-Fact
Signature date: 15 Sep 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EW transaction

Common Stock

Award

Transaction value: $0
Shares: +6,410
Change %: +52%
Price: $0.000000
Shares after: 18,796
Date: 11 Sep 2025
Ownership: Direct
Footnotes: F1

EW transaction

Common Stock

Tax liability

Transaction value: $50,420
Shares: -650
Change %: -3.5%
Price: $77.57
Shares after: 18,146
Date: 14 Sep 2025
Ownership: Direct

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These restricted stock units were granted on September 11, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.

SEC remarks

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. This Form 4 includes quarterly acquisition of shares under the Issuer's Employee Stock Purchase Plan.